The EIF2A Knockout NCI-H1975 Polyclonal Cells are a versatile CRISPR/Cas9-edited polyclonal cell population derived from the human non-small cell lung carcinoma line NCI-H1975. This product features a targeted disruption of the EIF2A gene, which encodes a critical translation initiation factor. The knockout model is provided as a polyclonal pool, reflecting a heterogeneous mixture of edited alleles suitable for pooled population studies rather than clonal analysis. Users should note that this is not a monoclonal cell line, and knockout status may vary among individual cells. The polyclonal format is ideal for investigating gene function in a bulk population context without the bias of single-cell expansion.
NCI-H1975 is a well-characterized human lung adenocarcinoma cell line harboring activating EGFR L858R and resistance-associated T790M mutations, representing a clinically relevant model of EGFR-targeted therapy resistance in non-small cell lung cancer. Established from a female patient, this line is widely used to study oncogenic signaling, drug resistance mechanisms, and tumor cell biology. The presence of dual EGFR mutations provides a unique genetic background for exploring the interplay between growth factor signaling and cellular stress pathways. As a model system, NCI-H1975 enables direct interrogation of how translation control mechanisms impact cancer cell survival, particularly under therapeutic stress.
EIF2A encodes a translation initiation factor that escorts initiator methionyl-tRNA (Met-tRNAi) to the 40S ribosomal subunit, facilitating both cap-dependent and cap-independent translation initiation. This factor is a central node in the integrated stress response (ISR), where it functions downstream of stress-sensing kinases such as EIF2AK3 (PERK), which phosphorylates the eIF2?? subunit (EIF2S1) to attenuate global translation while selectively promoting translation of stress-responsive mRNAs like ATF4 and CHOP. EIF2A also interacts with the guanine nucleotide exchange factor eIF2B and the regulatory phosphatase PPP1R15A/GADD34, which modulate eIF2?? phosphorylation dynamics. Additionally, EIF2A participates in stress granule assembly, cytoplasmic foci that form under stress to temporarily store untranslated mRNAs. Disruption of EIF2A is expected to perturb these tightly regulated processes, potentially altering translation reprogramming and stress adaptation.
In the NCI-H1975 background, knockout of EIF2A opens avenues to dissect the crosstalk between oncogenic EGFR signaling and translational control. The EGFR mutation-driven activation of downstream pathways such as mTOR may intersect with eIF2-mediated translation, and EIF2A loss could sensitize cells to ER stress or impair their ability to cope with therapeutic insults. Researchers can use this model to investigate how translation initiation factors influence drug tolerance, apoptotic thresholds, and the cellular response to proteotoxic or metabolic stress. Because NCI-H1975 cells rely on adaptive stress signaling for survival under kinase inhibitor treatment, EIF2A disruption may help elucidate mechanisms of acquired resistance or synthetic lethalities involving translation regulation.
Typical research applications for these polyclonal knockout cells include translation profiling via puromycin incorporation assays and polysome fractionation, stress granule dynamics assessed by immunofluorescence, and integrated stress response readouts such as RT-qPCR for ATF4 and CHOP or dual-luciferase uORF-ATF4 reporters. The model is well-suited for experiments with ER stress inducers like tunicamycin or thapsigargin, as well as for viral replication studies where host translation machinery is hijacked. Additional assays may involve Western blotting for total EIF2A and phosphorylated eIF2??, flow cytometry for apoptosis, and cell viability analysis under drug treatment. This gene-edited population serves as a powerful tool for dissecting translation-dependent stress signaling in NSCLC. For further technical information, please contact Ascent Research.
